Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06400810 · ClinicalTrials.gov registry record

Proximal Risk for Suicide in Adolescents

A clinical trial of Suicide and Mental Health Issue, sponsored by Oregon Health and Science University.

Recruiting
Registry status
144
Enrollment target
1
Study location

NCT06400810 is a study of Suicide and Mental Health Issue that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 144 participants, below the 6,988-participant average among 92 other Suicide trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06400810, a study of Suicide and Mental Health Issue, is actively recruiting participants, sponsored by Oregon Health and Science University.

RECRUITING
Registry status
144 participants
Enrollment target
1
Study location

Study Summary

The central hypothesis is that biometric data can continuously monitor and allow for early identification/intervention of escalating suicidal symptoms. The rationale is that improved outpatient monitoring through wearable technology can create a more objective platform to provide the ability to identify a worsening condition and utilize patient-specific just-in-time therapeutics developed with mental health providers for suicidal adolescents.

Interventions

  • DEVICE Analog Devices Inc.

Study Locations (1)

Oregon

  • OHSU - Portland

Trial Details

FieldValue
Enrollment Target 144 participants
Start Date 2023-06-15
Est. Completion 2026-07-01

What the Registry Record Tells You About NCT06400810

The ClinicalTrials.gov registry entry for NCT06400810 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,988-participant average among 92 other Suicide trials with a reported enrollment target (98% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Suicide appearing as the primary indexed condition, and to 1 intervention - of which Analog Devices Inc. is the first listed.

NCT06400810 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT06400810 about?

NCT06400810 is a clinical study titled "Proximal Risk for Suicide in Adolescents". The central hypothesis is that biometric data can continuously monitor and allow for early identification/intervention of escalating suicidal symptoms. The rationale is that improved outpatient monitoring through wearable technology can create a more objective platform to provide the ability to iden...

What is the current status of trial NCT06400810?

This trial is currently recruiting. The enrollment target is 144 participants. The study started on 2023-06-15. Estimated completion is 2026-07-01.

What conditions does trial NCT06400810 study?

This clinical trial studies the following conditions: Suicide, Mental Health Issue.

What interventions are being tested in trial NCT06400810?

The interventions under investigation include: Analog Devices Inc. (DEVICE).

Who is sponsoring clinical trial NCT06400810?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06400810 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.